GlassScriptPhysician profile
Eric D Castellucci
NPI 1316989437
$2,985.38
in general payments reported to CMS, 2019-2025
13 companies · $250 in 2025
The $250 reported for 2025 was more than what 86% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $663 · 2020: $186 · 2021: $299 · 2022: $525 · 2023: $493 · 2024: $569 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,292 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,292.33 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $830.82 | 2019-2025 | Andexxa, Airsupra |
| Janssen Pharmaceuticals, INC | $575.75 | 2020-2024 | Xarelto |
| Inari Medical, INC. | $396.20 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Portola Pharmaceuticals, LLC | $203.91 | 2019-2020 | |
| Medtronic, INC. | $167.51 | 2024-2025 | Emprint, Kyphon Express II Kyphopak Tray |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $149.09 | 2019-2020 | |
| Csl Behring | $144.99 | 2024 | Kcentra |
| Grifols USA, LLC | $123.84 | 2022 | |
| Vifor Pharma, INC. | $122.40 | 2021 | |
| Vapotherm INC | $121.62 | 2019 | |
| Nabriva Therapeutics, Plc | $99.66 | 2020 | |
| Pfizer INC. | $32.31 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $17.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Castellucci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.